Search research articles
Contact Us
Filters
Showing results (91-100 of 115) with videos related to
Page
of 12
Sort By:
The Annals of Thoracic Surgery
|
November 24, 2018
Adjuvant Chemotherapy Improves Survival in Surgically Resected Stage IB Squamous Lung Cancer
Jianlin Xu, Shuyuan Wang, Hua Zhong, et al.
Translational Lung Cancer Research
|
October 24, 2025
Potential efficacy of anti-angiogenic therapy combined with immunotherapy for advanced SMARCA4-deficient thoracic tumor: a retrospective study
Beibei Liu, Danni Wang, Yujing Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 30, 2023
PEG2000-PLA-based nanoscale polymeric micelles reduce paclitaxel-related toxicity in beagle dogs
Jun Lu, Bo Han, Bo Zhang, et al.
Clinical Lung Cancer
|
January 5, 2016
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung Cancer
Jianlin Xu, Tianqing Chu, Bo Jin, et al.
ACS Nano
|
April 7, 2026
Fusogenic Liposome-Mediated Extracellular Vesicles MicroRNA Profiling for Lung Cancer Diagnosis
Fanyu Meng, Ruimin Wang, Wenjun Yu, et al.
Translational Oncology
|
July 2, 2026
DAZAP2, regulated by miR-125b, contributes to inflammation-related non-small cell lung cancer progression
Yanwei Zhang, Beibei Sun, Yabin Tang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 3, 2021
Solid subtype predicts early bone metastases in sensitive EGFR-mutated lung adenocarcinoma patients after surgery
Anning Xiong, Changhui Li, Jianlin Xu, et al.
BMJ Open
|
March 25, 2026
Safety and efficacy of intrathecal pemetrexed and bevacizumab in non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): protocol for a single-arm, prospective, phase Ia trial
Yanbin Kuang, Jiajun Teng, Weimin Wang, et al.
Cancer Medicine
|
January 13, 2022
The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma
Wensheng Zhou, Zhichao Liu, Yanan Wang, et al.
International Journal of Cancer
|
June 1, 2017
Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial
Baohui Han, Bo Jin, Tianqing Chu, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 115) with videos related to
Sort By:
Page
of 12
The Annals of Thoracic Surgery
|
November 24, 2018
Adjuvant Chemotherapy Improves Survival in Surgically Resected Stage IB Squamous Lung Cancer
Jianlin Xu, Shuyuan Wang, Hua Zhong, et al.
Translational Lung Cancer Research
|
October 24, 2025
Potential efficacy of anti-angiogenic therapy combined with immunotherapy for advanced SMARCA4-deficient thoracic tumor: a retrospective study
Beibei Liu, Danni Wang, Yujing Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 30, 2023
PEG2000-PLA-based nanoscale polymeric micelles reduce paclitaxel-related toxicity in beagle dogs
Jun Lu, Bo Han, Bo Zhang, et al.
Clinical Lung Cancer
|
January 5, 2016
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung Cancer
Jianlin Xu, Tianqing Chu, Bo Jin, et al.
ACS Nano
|
April 7, 2026
Fusogenic Liposome-Mediated Extracellular Vesicles MicroRNA Profiling for Lung Cancer Diagnosis
Fanyu Meng, Ruimin Wang, Wenjun Yu, et al.
Translational Oncology
|
July 2, 2026
DAZAP2, regulated by miR-125b, contributes to inflammation-related non-small cell lung cancer progression
Yanwei Zhang, Beibei Sun, Yabin Tang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 3, 2021
Solid subtype predicts early bone metastases in sensitive EGFR-mutated lung adenocarcinoma patients after surgery
Anning Xiong, Changhui Li, Jianlin Xu, et al.
BMJ Open
|
March 25, 2026
Safety and efficacy of intrathecal pemetrexed and bevacizumab in non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): protocol for a single-arm, prospective, phase Ia trial
Yanbin Kuang, Jiajun Teng, Weimin Wang, et al.
Cancer Medicine
|
January 13, 2022
The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma
Wensheng Zhou, Zhichao Liu, Yanan Wang, et al.
International Journal of Cancer
|
June 1, 2017
Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial
Baohui Han, Bo Jin, Tianqing Chu, et al.
Page
of 12